HGF and the regulation of tight junctions in human prostate cancer cells

  • Authors:
    • Tracey A. Martin
    • Malcolm D. Mason
    • Wen G. Jiang
  • View Affiliations

  • Published online on: May 26, 2014     https://doi.org/10.3892/or.2014.3219
  • Pages: 213-224
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hepatocyte growth factor (HGF) may impact the metastasis of prostate cancer via its action on prostate stem cells or their progeny. Tight junctions (TJs) are crucial to the process of metastasis and have been previously shown to be regulated by HGF. The present study aimed to evaluate the effect of HGF on the function of TJs in human prostate epithelial, prostate stem cell-like and prostate cancer cell lines. Four human prostate cancer cell lines (PC-3, DU-145, PZHPV-7, CaHPV-10), normal adult prostate parental epithelial cells (RWPE-1) and a stem cell-like derivative of RWPE-1 (WPE-STEM) were used to assess HGF-induced changes in TJs. A significant difference was noted in the behaviour between the WPE-STEM, RWPE-1 and the cancer cell lines which was HGF concentration-dependent. However, in the WPE-STEM cells, the effect was biphasic, with the cells seemingly resistant to HGF-modulated TJ disruption. Closer examination revealed that HGF affected the redistribution of ZO-1, ZO-2 and ZO-3 away from the TJs of confluent cells with concurrent loss of claudin-1 and claudin-5, and western blot analysis revealed a loss in TJ protein expression of ZO-1 and ZO-2. We demonstrated for the first time that HGF regulates TJ function in human prostate cells. Moreover, this regulation was dependent on the tumourigenicity of the cells, with the most aggressive cells most susceptible and the stem cell-like cells least susceptible. These data offer an intriguing glimpse of how TJs affect the behaviour of prostate cancer cells and how HGF modulates the expression and function of the molecules maintaining TJ structure and function.

References

1 

Martin TA, Watkins G, Mansel RE and Jiang WG: Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer. 40:2717–2725. 2004. View Article : Google Scholar : PubMed/NCBI

2 

Martin TA, Mansel RE and Jiang WG: Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells. J Cell Physiol. 192:268–275. 2002. View Article : Google Scholar

3 

Ren J, Hamada J, Takeichi N, Fujikawa S and Kobayashi H: Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary carcinoma. Cancer Res. 50:358–362. 1990.

4 

Satoh H, Zhong Y, Isomura H, et al: Localization of 7H6 tight junction-associated antigen along the cell border of vascular endothelial cells correlates with paracellular barrier function against ions, large molecules, and cancer cells. Exp Cell Res. 222:269–274. 1996. View Article : Google Scholar

5 

Hoevel T, Macek R, Mundigl O, Swisshelm K and Kubbies M: Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol. 191:60–68. 2002. View Article : Google Scholar : PubMed/NCBI

6 

Kominsky SL, Argani P, Korz D, et al: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 22:2021–2033. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Krämer F, White K, Kubbies M, Swisshelm K and Weber BH: Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet. 7:249–256. 2002.PubMed/NCBI

8 

Chlenski A, Ketels KV, Korovaitseva GI, Talamonti MS, Oyasu R and Scarpelli DG: Organization and expression of the human zo-2 gene (tjp-2) in normal and neoplastic tissues. Biochim Biophys Acta. 1493:319–324. 2000. View Article : Google Scholar : PubMed/NCBI

9 

Bell J, Walsh S, Nusrat A and Cohen C: Zonula occludens-1 and Her-2/neu expression in invasive breast carcinoma. Appl Immunohistochem Mol Morphol. 11:125–129. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Martin TA, Watkins G, Mansel RE and Jiang WG: Hepatocyte growth factor disrupts tight junctions in human breast cancer cells. Cell Biol Int. 28:361–371. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Ikenouchi J, Matsuda M, Furuse M and Tsukita S: Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci. 116:1959–1967. 2003. View Article : Google Scholar

12 

Martin TA, Goyal A, Watkins G and Jiang WG: Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol. 12:488–496. 2005. View Article : Google Scholar : PubMed/NCBI

13 

Ohkubo T and Ozawa M: The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci. 117:1675–1685. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Gopalakrishnan S, Raman N, Atkinson SJ and Marrs JA: Rho GTPase signaling regulates tight junction assembly and protects tight junctions during ATP depletion. Am J Physiol. 275:C798–C809. 1998.PubMed/NCBI

15 

Wong V and Gumbiner BM: A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol. 136:399–409. 1997. View Article : Google Scholar : PubMed/NCBI

16 

Krajewska M, Olson AH, Mercola D, Reed JC and Krajewski S: Claudin-1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate. Prostate. 67:907–910. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Hewitt KJ, Agarwal R and Morin PJ: The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer. 6:1862006. View Article : Google Scholar : PubMed/NCBI

18 

Zheng JY, Yu D, Foroohar M, Ko E, Chan J, Kim N, Chiu R and Pang S: Regulation of the expression of the prostate-specific antigen by claudin-7. J Membr Biol. 194:187–197. 2003. View Article : Google Scholar : PubMed/NCBI

19 

Long H, Crean CD, Lee WH, Cummings OW and Gabig TG: Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res. 61:7878–7881. 2001.

20 

Meyer HW, Freytag C, Freytag T and Richter W: Effect of proteases and other treatments on the proliferative assembly of tight junction strands in the rat prostate tissue. Exp Pathol. 34:237–244. 1998. View Article : Google Scholar : PubMed/NCBI

21 

Kachar B and Reese TS: Evidence for the lipidic nature of tight junction strands. Nature. 296:464–466. 1982. View Article : Google Scholar : PubMed/NCBI

22 

Kachar B and Reese TS: Formation of misplaced and reflexive tight junction strands in prostate epithelial cells. J Ultrastruct Res. 82:90–95. 1983. View Article : Google Scholar : PubMed/NCBI

23 

Kachar B and Pinto da Silva P: Rapid massive assembly of tight junction strands. Science. 213:541–544. 1981. View Article : Google Scholar : PubMed/NCBI

24 

Martin TA, Das T, Mansel RE and Jiang WG: Enhanced tight junction function in human breast cancer cells by antioxidant, selenium and polyunsaturated lipid. J Cell Biochem. 101:155–166. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Jiang WG, Martin TA, Matsumoto K, Nakamura T and Mansel RE: Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J Cell Physiol. 181:319–329. 1999. View Article : Google Scholar

26 

Rosen EM, Zitnik RJ, Elias JA, Bhargava MM, Wines J and Goldberg ID: The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis. EXS. 65:301–310. 1993.PubMed/NCBI

27 

Martin TA and Jiang WG: Tight junctions and their role in cancer metastasis. Histol Histopathol. 16:1183–1195. 2001.PubMed/NCBI

28 

Hurle RA, Davies G, Parr C, Mason MD, Jenkins SA, Kynaston HG and Jiang WG: Hepatocyte growth factor/scatter factor and prostate cancer: a review. Histol Histopathol. 20:1339–1349. 2005.PubMed/NCBI

29 

Davies G, Jiang WG and Mason MD: Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res. 7:3289–3297. 2001.

30 

Jin M, Barron E, He S, Ryan SJ and Hinton DR: Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor. Invest Ophthalmol Vis Sci. 43:2782–2790. 2002.PubMed/NCBI

31 

Catizone A, Ricci G and Galdieri M: Hepatocyte growth factor modulates Sertoli-Sertoli tight junction dynamics. J Cell Physiol. 216:253–260. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Grisendi S, Arpin M and Crepaldi T: Effect of hepatocyte growth factor on assembly of zonula occludens-1 protein at the plasma membrane. J Cell Physiol. 176:465–471. 1998. View Article : Google Scholar : PubMed/NCBI

33 

Hollande F, Blanc EM, Bali JP, Whitehead RH, Pelegrin A, Baldwin GS and Choquet A: HGF regulates tight junctions in new nontumorigenic gastric epithelial cell line. Am J Physiol Gastrointest Liver Physiol. 280:G910–G921. 2001.PubMed/NCBI

34 

Nusrat A, Parkos CA, Bacarra AE, Godowski PJ, Delp-Archer C, Rosen EM and Madara JL: Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J Clin Invest. 93:2056–2065. 1994.

35 

Shen BQ, Panos RJ, Hansen-Guzmán K, Widdicombe JH and Mrsny RJ: Hepatocyte growth factor stimulates the differentiation of human tracheal epithelia in vitro. Am J Physiol. 272:L1115–L1120. 1997.PubMed/NCBI

36 

Date I, Takagi N, Takagi K, Tanonaka K, Funakoshi H, Matsumoto K, Nakamura T and Takeo S: Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. Neurosci Lett. 407:141–145. 2006. View Article : Google Scholar

37 

Grant-Tschudy KS and Wira CR: Hepatocyte growth factor regulation of uterine epithelial cell transepithelial resistance and tumor necrosis factor alpha release in culture. Biol Reprod. 72:814–821. 2005. View Article : Google Scholar

38 

Liu F, Schaphorst KL, Verin AD, Jacobs K, Birukova A, Day RM, Bogatcheva N, Bottaro DP and Garcia JG: Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB J. 16:950–962. 2002. View Article : Google Scholar

39 

Fanning AS, Mitic LL and Anderson JM: Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol. 10:1337–1345. 1999.PubMed/NCBI

40 

Farshori P and Kachar B: Redistribution and phosphorylation of occludin during opening and resealing of tight junctions in cultured epithelial cells. J Membr Biol. 170:147–156. 1999. View Article : Google Scholar : PubMed/NCBI

41 

Wong V: Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol. 273:C1859–C1867. 1997.PubMed/NCBI

42 

Morita K, Furuse M, Fujimoto K and Tsukita S: Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA. 96:511–516. 1999. View Article : Google Scholar : PubMed/NCBI

43 

Busch C, Hanssen TA, Wagener C and OBrink B: Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol. 33:290–298. 2002. View Article : Google Scholar : PubMed/NCBI

44 

Shin DY, Lee WS, Jung JH, et al: Flavonoids from Orostachys japonicus A. Berger inhibit the invasion of LNCaP prostate carcinoma cells by inactivating Akt and modulating tight junctions. Int J Mol Sci. 14:18407–18420. 2013.PubMed/NCBI

45 

Meng J, Mostaghel EA, Vakar-Lopez F, Montgomery B, True L and Nelson PS: Testosterone regulates tight junction proteins and influences prostatic autoimmune responses. Horm Cancer. 2:145–156. 2011. View Article : Google Scholar : PubMed/NCBI

46 

Maeda T, Murata M, Chiba H, Takasawa A, Tanaka S, Kojima T, Masumori N, Tsukamoto T and Sawada N: Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer. Prostate. 72:351–360. 2012. View Article : Google Scholar

47 

Nishida S, Hirohashi Y, Torigoe T, Inoue R, Kitamura H, Tanaka T, Takahashi A, Asanuma H, Masumori N, Tsukamoto T and Sato N: Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor. Cancer Sci. 104:431–436. 2013. View Article : Google Scholar : PubMed/NCBI

48 

van Leenders GJ, Sookhlall R, Teubel WJ, de Ridder CM, Reneman S, Sacchetti A, Vissers KJ, van Weerden W and Jenster G: Activation of c-MET induces a stem-like phenotype in human prostate cancer. PLoS One. 6:e267532001.PubMed/NCBI

Related Articles

Journal Cover

July 2014
Volume 32 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Martin, T.A., Mason, M.D., & Jiang, W.G. (2014). HGF and the regulation of tight junctions in human prostate cancer cells. Oncology Reports, 32, 213-224. https://doi.org/10.3892/or.2014.3219
MLA
Martin, T. A., Mason, M. D., Jiang, W. G."HGF and the regulation of tight junctions in human prostate cancer cells". Oncology Reports 32.1 (2014): 213-224.
Chicago
Martin, T. A., Mason, M. D., Jiang, W. G."HGF and the regulation of tight junctions in human prostate cancer cells". Oncology Reports 32, no. 1 (2014): 213-224. https://doi.org/10.3892/or.2014.3219